TI
MDCO

Trexquant Investment’s Medicines Co MDCO Stock Holding History

Trexquant Investment’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-11,784
Closed -$352K – 1439
2018
Q3 		$352K Sell
11,784
-15,630
-57% -$589K 0.03% 642
2018
Q2 		$1.01M Buy
+27,414
New +$891K 0.07% 373
2018
Q1 		– Sell
-23,340
Closed -$638K – 1528
2017
Q4 		$638K Buy
23,340
+10,840
+87% +$334K 0.07% 423
2017
Q3 		$463K Buy
12,500
+4,747
+61% +$175K 0.12% 303
2017
Q2 		$295K Sell
7,753
-8,547
-52% -$381K 0.08% 475
2017
Q1 		$797K Buy
+16,300
New +$743K 0.1% 353
2016
Q4 		– Sell
-6,000
Closed -$226K – 1221
2016
Q3 		$226K Sell
6,000
-12,887
-68% -$486K 0.05% 593
2016
Q2 		$635K Buy
18,887
+3,687
+24% +$130K 0.08% 390
2016
Q1 		$483K Buy
+15,200
New +$496K 0.06% 559
2015
Q1 		– Sell
-30,061
Closed -$831K – 1279
2014
Q4 		$831K Buy
+30,061
New +$745K 0.15% 232

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Trexquant Investment's MDCO Position: Q4 2018 in Review

Trexquant Investment sold out of Medicines Co (MDCO) in Q4 2018, closing a stake of 11,784 shares — an estimated $352K sold.

Trexquant Investment first reported a position in MDCO in Q4 2014 and held it in 10 quarters. The position peaked at $1.01M in Q2 2018. 188 funds tracked by Wall St. Rank hold MDCO as of Q4 2018.

  • Trexquant Investment reported no remaining Medicines Co position as of Q4 2018 after selling out during the quarter.
  • Trexquant Investment sold 11,784 Medicines Co shares in Q4 2018, an estimated $352K.
  • Trexquant Investment first reported a position in Medicines Co in Q4 2014 and held it in 10 quarters.
  • Trexquant Investment's Medicines Co position peaked at $1.01M in Q2 2018.
  • 188 funds tracked by Wall St. Rank held Medicines Co as of Q4 2018.

Based on Trexquant Investment's 13F filing for Q4 2018, filed 13 Feb 2019.